MAPT and Alzheimer disease: Moreover, a degree of non-specific cross-reactivity of the human tTau and p181-Tau assays with mouse Tau is suggested by low levels in non−3xTg-AD mice (Figure 2b,e–g), consistent with previous observations [44].